Use of recombinant human erythropoietin (r-HuEPO) in an injured Jehovah's witness patient;Traitement d'une anemie aigue post-traumatique par erythropoietine humaine recombinante chez un temoin de Jehovah

Annales Francaises d'Anesthesie et de Reanimation

Volumn 15, Issue 8, 1996, Pages 1199-1202

  Streef, C ^a   Charpentier, C ^a   Audibert, G ^a   Laxenaire, M C ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

erythropoietin; Jehovah's witness; transfusion

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN; HEMOGLOBIN;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CASE REPORT; FEMUR FRACTURE; HUMAN; MALE; RELIGION; SAFETY; ACUTE DISEASE; ADULT; FEMORAL ARTERY; FEMORAL VEIN; INJURY; IRON DEFICIENCY ANEMIA; TIME;

ACUTE DISEASE; ADULT; ANEMIA, HYPOCHROMIC; BLOOD LOSS, SURGICAL; CHRISTIANITY; ERYTHROPOIETIN, RECOMBINANT; FEMORAL ARTERY; FEMORAL FRACTURES; FEMORAL VEIN; HEMOGLOBINS; HUMANS; MALE; TIME FACTORS;

EID: 0030470759     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(97)85879-0     Document Type: Article

References (22)

1. 1 Rothstein P, Roye D, Verdisco L, Stern L. Preoperative use of erythropoietin in an adolescent Jehovah witness. Anesthesiology 1990;73:568-70
2. 2 Madura JA. Use of erythropoietin and parenteral iron dextran in a severely anemic Jehovah's witness with colon cancer. Arch Surg 1993;128:1168-70
3. 3 Fullerton DA, Campbell DN, Whitman GJR. Use of human recombinant erythropoietin to correct severe preoperative anemia. Ann Thorac Surg 1991;51:825-6
4. 4 Koestner JA, Nelson LD, Morris JA, Safcsak K. Use of recombinant human erythropoietin (r-HuEPO) in a Jehovah's witness refusing transfusion of blood products: case report. J Trauma 1990;30:1406-8
5. 5 Estioko MR, Litwak RS, Rand JH. Reoperation, emergency, and urgent open cardiac surgery in Jehovah's Witness. Chest 1992;102:50-3
6. 6 Najan A. L'expérience des témoins de Jéhovah. In: Gromb S, Garay A. eds Consentement éclairé et transfusion sanguine. Rennes: ENSP, 1996:107-22
7. 7 Rouge D, Telmon L, Dulac P, Arbus L. Le refus de transfusion sanguine. L'exemple des Témoins de Jéhovah. Le Concours Médical 1993;115:3107-10
8. 8 Bagou G, Laplace MC. L'anesthésiste-réanimateur et le témoin de Jéhovah. Ann Fr Anesth Réanim 1991;10:354-61
9. 9 Najand A. Anesthésiste-réanimateur et témoins de Jéhovah. Ann Fr Anesth Réanim 1992;11:237-40
10. 10 Gromb S, Janvier J. Transfusion sanguine et témoins de Jéhovah. Presse Méd 1996;25:180-2
11. 11 Pertek JP, Decroix G. À propos du refus de transfusion sanguine par le patient. Ann Fr Anesth Réanim 1992;11:236-7
12. 12 Bruce R, Smoller MD, Margot S, Kruskall MD. Phlebotomy for diagnostic laboratory tests in adults: pattern of use and effect on transfusion requirements. N Engl J Med 1986;19:1233-5
13. 13 Akingbola OA, Custer JR, Bunchman TE, Sedman AB. Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient. Crit Care Med 1994;22:524-8
14. 14 Nearman HS, Eckhauser ML. Postoperative management of a severely anemic Jehovah's Witness. Crit Care Med 1983;11:142-3
15. 15 Lichtenstein A, Eckhart WF, Swanson KJ, Vacanti CA, Zapol WM. Unplanned intraoperative and postoperative hemodilution: oxygen transport and consumption during severe anemia. Anesthesiology 1988;69:119-22
16. 16 Mac Dougall IC, Davies ME, Hutton RD, Coles GA, Williams JD. Rheological studies during treatment of renal anaemia with recombinant human erythropoietin. Br J Haematol 1991;77:750-8
17. 17 Pertek JP, Coissard A, Decroix G. À propos du refus de transfusion sanguine des témoins de Jéhovah. Ann Fr Anesth Réanim 1996;15:695-6
18. 18 Egrie JC, Strickland TW, Lane J, Aoki K, Cohen AM, Smalling R et al. Characterization and biological effects of recombinant human erythropoietin. Immunobiology 1986;172:213-24
19. 19 Eschbach JW, Egrie JC, Downing MR. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987;316:73-8
20. 20 Law EJ, Still JM, Gattis CS. The use of erythropoietin in two burned patients who are Jehovah's Witnesses. Burns 1991;17:75-7
21. 21 Mercuriali F. Zanella A, Barosi G, Inghilleri G, Biffi E, Vinci A et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55-60
22. 22 Goodnough LT. Erythropoietin as a pharmacologic alternative to blood transfusion in the surgical patient. Transf Med Rev 1990;4:288-96